Kiadis Pharma N.V. announced the appointment of Dr. Andrew Sandler as chief medical officer, effective October 1, 2017. Dr. Sandler will take over the role from Dr. Jeroen Rovers who will work closely with Dr. Sandler until the end of 2017, as part of a planned transition. Dr. Sandler will be a member of the executive management team and will oversee the overall medical function and strategy of the company, including clinical development, regulatory affairs, pharmacovigilance and medical affairs. Dr. Sandler has over 20 years of experience within the healthcare industry, dedicated to hematologic malignancies and solid tumors. Most recently, Dr. Sandler was senior vice president, medical affairs, at medivation. Prior to that he was CMO at Dendreon pharmaceuticals and Spectrum Pharma.